Antibodies directed to pig non-Gal antigens in naive and sensitized baboons

被引:62
作者
Ezzelarab, M.
Hara, H.
Busch, J.
Rood, P. P. M.
Zhu, X.
Ibrahim, Z.
Ball, S.
Ayares, D.
Awwad, M.
Cooper, D. K. C.
机构
[1] Univ Pittsburgh, Thomas E Starzl Transplantat Inst, Med Ctr, Pittsburgh, PA 15261 USA
[2] Revivicor Inc, Blacksburg, VA USA
关键词
alpha; 1; 3-galactosyltransferase gene-knockout; anti-pig antibodies; baboon; cytotoxicity; Gal alpha 1; 3Gal; pig; xenotransplantation;
D O I
10.1111/j.1399-3089.2006.00320.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: As pigs homozygous for alpha 1,3-galactosyltransferase gene-knockout (GT-KO) are available, primate antibodies to pig non-Gal antigens can be studied. Methods: Sera from 56 baboons were tested for binding of IgM and IgG to peripheral blood mononuclear cells (PBMC) from both wild-type (WT) and GT-KO pigs by flow cytometry. Complement-dependent cytotoxicity was measured in 39 sera. Antibody and cytotoxicity responses were measured in two baboons exposed to a GT-KO pig heart, one not immunosuppressed and one that received only cobra venom factor. Results: IgM and IgG bound to 95% and 79% of WT PBMC, and 32% and 9% GT-KO PBMC, respectively (WT vs. GT-KO, P < 0.01). Whereas 97% of sera were cytotoxic to WT PBMC, only 64% were cytotoxic to GT-KO PBMC, and the level of cytotoxicity was less (mean 60% vs. 25% lysis, P < 0.05). In the two baboons exposed to GT-KO hearts, anti-non-Gal antibodies increased markedly, peaking after 2 (IgM) and 3 (IgG) weeks, associated with an increase in lysis of GT-KO PBMC. Conclusions: Two-thirds of baboon sera demonstrated cytotoxicity to GT-KO PBMC. After GT-KO organ transplantation, if an elicited antibody response develops, it is likely to cause rapid graft rejection.
引用
收藏
页码:400 / 407
页数:8
相关论文
共 25 条
  • [1] Baumann BC, 2005, XENOTRANSPLANTATION, V12, P375
  • [2] Bühler L, 2000, TRANSPLANTATION, V69, P2296
  • [3] COLLINS BH, 1995, J IMMUNOL, V154, P5500
  • [4] Cooper D K, 1993, Transpl Immunol, V1, P198, DOI 10.1016/0966-3274(93)90047-C
  • [5] COOPER DKC, 1988, J HEART TRANSPLANT, V7, P238
  • [6] Xenoantigens and xenoantibodies
    Cooper, DKC
    [J]. XENOTRANSPLANTATION, 1998, 5 (01) : 6 - 17
  • [7] Carbohydrates in xenotransplantation
    Ezzelarab, M
    Ayares, D
    Cooper, DKC
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2005, 83 (04) : 396 - 404
  • [8] GALILI U, 1988, J BIOL CHEM, V263, P17755
  • [9] GOOD AH, 1992, TRANSPL P, V24, P559
  • [10] Hara H, 2005, XENOTRANSPLANTATION, V12, P385